Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
28 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/halozyme-to-participate-at-upcoming-investor-conferences-302467398.html
06 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/halozyme-raises-2025-financial-guidance-ranges-and-reports-strong-first-quarter-2025-results-302447541.html
05 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/halozyme-to-participate-in-the-bofa-securities-2025-healthcare-conference-302446419.html
28 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/halozyme-to-report-first-quarter-2025-financial-and-operating-results-302439254.html
28 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/halozyme-announces-argenx-received-positive-chmp-opinion-for-vyvgart-efgartigimod-alfa-subcutaneous-injection-with-enhanze-for-chronic-inflammatory-demyelinating-polyneuropathy-cidp-302439359.html
25 Apr 2025
// PRESS RELEASE
https://www.prnewswire.com/news-releases/halozyme-sues-merck-for-patent-infringement-over-subcutaneous-keytruda-formulation-302437331.html
Inspections and registrations
ABOUT THIS PAGE
Halozyme Therapeutics is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of ENHANZE DRUG PRODUCT bulk with DMF offered by Halozyme Therapeutics